Arterial hypertension continues to be a major risk factor for premature cardiovascular
morbidity and mortality worldwide. Blood pressure control rates remain stubbornly low …

Recently, resistant hypertension has received a significant amount of attention, due to its
high prevalence among treated hypertensive patients as well as controversies regarding …

A proportion of patients with hypertension continue to have elevation of blood pressure
resistant to treatment with several medication classes. This situation causes great concern to …

Resistant hypertension remains a clinical challenge with few management options beyond
maximisation of medications. Catheter-based renal artery denervation (RDN) was proposed …

Resistant hypertension is a condition with severe morbidity and mortality, yet current
treatment is limited in scope and efficacy. Historically, surgical sympathetic denervation has …

The year 2014 was a turning point for the field of renal denervation (RDN) and its potential
use to treat resistant hypertension. Tremendous enthusiasm shifted to sober reflection on the …

Hypertension is very common throughout the world's population, which many people are
unaware of, but it is still rising in population and causing a major public health problem. One …

Background Prior unblinded studies have suggested that catheter-based renal-artery
denervation reduces blood pressure in patients with resistant hypertension. Methods We …

Background: Percutaneous renal denervation (RDN) was heralded as a novel approach to
treat resistant hypertension (RH), however evidence supporting its efficacy is conflicting. We …

There is little guidance for the management of drug-resistant hypertension in existing
guidelines due largely to an absence of clinical trials with hard cardiovascular outcomes; …